Biomolecular Systems is a glycobiology focused research department of the Max Planck Institute of Colloids and Interfaces, located in Potsdam, Golm, and Berlin, Dahlem. Established as a topnotch chemistry center lead by Prof. Peter H. Seeberger, BMS employs 85 scientists from 18 different countries and diverse scientific backgrounds. Our expertise lies in synthetic chemistry, structural glycobiology, glycomics, glycoproteomics, biomimetics, glycoimmunology and carbohydrate vaccines development. Our research is orientated towards the medical implication and application of carbohydrates or glycans. We work in an interdisciplinary field known as Chemical Biology. Currently, we are developing diagnostics, medicines and vaccines against some of the world´s deadliest diseases: malaria, pneumonia, tuberculosis, cancer, HIV/AIDS, plague, and many others.
Here, we blog about glycoscience, lab fab, science communication and science entrepreneurship, through the mind & finger tips of ex-scientist turned mother, turned entrepreneur, turned to science again, Dr. Dana Kikic.